Get your free ETF data sample from our comprehensive offerings. Start your free trial→

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

›ETF Issuers›VanEck›PPH
PPH

VanEck Pharmaceutical ETF

Passive ETFEquity

The PPH Exchange Traded Fund (ETF) is provided by VanEck. It is built to track an index: MVIS US Listed Pharmaceutical 25 Index. The PPH ETF provides physical exposure, so by buying it you actually own parts of all the 25 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

Diversification
Data as of 08/31/26
No. of holdings
25
Effective diversification
12.1
Total weight of top 15 holdings
90.56%
Top 15 Holdings
Data as of 08/31/26
Eli Lilly & Co.
19.11%
Merck & Co., Inc.
10.96%
Novartis AG
10.06%
Pfizer Inc.
5.05%
Bristol Myers Squibb Co.
4.98%
Novo Nordisk A/S
4.92%
McKesson Corp.
4.70%
AbbVie, Inc.
4.48%
Johnson & Johnson
4.43%
GSK Plc
4.13%
Sanofi
4.06%
Cencora, Inc.
3.68%
AstraZeneca PLC
3.59%
Haleon Plc
3.23%
Teva Pharmaceutical Industries Ltd.
3.17%
Sector exposures
Data as of 08/31/26
Healthcare
020%40%60%80%100%
Country exposures
Data as of 08/31/26
USA
United Kingdom
Switzerland
Denmark
France
Israel
Japan
Ireland
Other
020%40%60%70%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight